A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
dc.contributor | Hospital General de Granollers |
dc.contributor.author | Soler, Alfons |
dc.contributor.author | Garcia Sanchez, Ricarda |
dc.contributor.author | Pérez Persona, Ernesto |
dc.contributor.author | Arnao Herraiz, Mario |
dc.contributor.author | García-Guiñón, Antoni |
dc.contributor.author | Domingo, Abel |
dc.contributor.author | González Pardo, Miriam |
dc.contributor.author | de la Rubia, Javier |
dc.contributor.author | Mateos, María-Victoria |
dc.contributor.author | Ríos-Tamayo, Rafael |
dc.date.accessioned | 2023-04-26T11:28:45Z |
dc.date.available | 2023-04-26T11:28:45Z |
dc.date.issued | 2023-02-19 |
dc.identifier.citation | Ríos-Tamayo R, Soler JA, García-Sánchez R, Pérez Persona E, Arnao M, García-Guiñón A, et al. A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study. Hematology. 2023 Dec;28(1):2178997. |
dc.identifier.uri | https://hdl.handle.net/11351/9425 |
dc.description | Mieloma múltiple recidivant-refractari; Anticossos monoclonals; Estudi observacional multicèntric |
dc.language.iso | eng |
dc.publisher | Taylor & Francis |
dc.relation.ispartofseries | Hematology;28(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mieloma múltiple |
dc.subject | Anticossos monoclonals |
dc.subject | Medicaments - Eficàcia |
dc.subject.mesh | Multiple Myeloma |
dc.subject.mesh | Antibodies, Monoclonal |
dc.subject.mesh | Multicenter Study |
dc.title | A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1080/16078454.2023.2178997 |
dc.subject.decs | mieloma múltiple |
dc.subject.decs | anticuerpos monoclonales |
dc.subject.decs | estudio multicéntrico |
dc.relation.publishversion | https://doi.org/10.1080/16078454.2023.2178997 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Ríos-Tamayo R] Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. [Soler JA] Department of Hematology, HospitalUniversitari Parc Taulí de Sabadell, Catalonia, Spain. [García-Sánchez R] Department of Hematology, Hospital Virgen de la Victoria, Málaga, Spain. [Pérez Persona E] Department of Hematology, Hospital Universitario de Navarra, Pamplona, Spain. [Arnao M] Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain. [García-Guiñón A] Department of Hematology, Hospital Universitari Arnau de Vilanova, Lleida, Spain. [Domingo A] Department of Hematology, Hospital General de Granollers, Granollers, Spain. [González-Pardo M] Medical Department, Janssen-Cilag España, Spain. [de la Rubia J] Hospital Universitari i Politècnic La Fe, Valencia, Spain. Hematology Department, Universidad Católica“San Vicente Mártir”, Valencia, Spain. CIBERONC CB16/12/00284,Valencia, Spain. [Mateos MV] Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Hospital Universitario de Salamanca, Salamanca, Spain |
dc.identifier.pmid | 36803194 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |